Alessandro Riva1 article listing Alessandro Riva in Nature Communications, indexed by Paperzzz from Crossref and OSF.A viral-based individualized neoantigen vaccine as adjuvant treatment in resected head and neck squamous cell carcinoma: a randomized Phase I trial Nature Communications